Targeting the Microenvironment in High Grade Serous Ovarian Cancer

Targeting the Microenvironment in High Grade Serous Ovarian Cancer

Cancer–stroma interactions play a key role in cancer progression and response to standard chemotherapy. Here, we provide a summary of the mechanisms by which the major cellular components of the ovarian cancer (OC) tumor microenvironment (TME) including cancer-associated fibroblasts (CAFs)...

Full description

Bibliographic Details
Main Authors:	Nkechiyere G. Nwani, Livia E. Sima, Wilberto Nieves-Neira, Daniela Matei
Format:	Article
Language:	English
Published:	MDPI AG 2018-08-01
Series:	Cancers
Subjects:	high-grade serous ovarian cancer tumor microenvironment angiogenesis immune response metastasis therapeutic targeting strategies
Online Access:	http://www.mdpi.com/2072-6694/10/8/266

Similar Items

Digital pathology-based study of cell- and tissue-level morphologic features in serous borderline ovarian tumor and high-grade serous ovarian cancer
by: Jun Jiang, et al.
Published: (2021-01-01)

Dynamics of the Tumor Immune Microenvironment during Neoadjuvant Chemotherapy of High-Grade Serous Ovarian Cancer
by: Joung, J.-G, et al.
Published: (2022)

Proteome profiling of low grade serous ovarian cancer
by: Haniyeh Bashi zadeh fakhar, et al.
Published: (2019-07-01)

Low-grade serous carcinoma with extensive osseous metaplasia arising from ovarian serous cystadenofibroma
by: Renan Ribeiro e Ribeiro, et al.
Published: (2021-05-01)

Cell Origins of High-Grade Serous Ovarian Cancer
by: Jaeyeon Kim, et al.
Published: (2018-11-01)

Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
by: Huan Wu, et al.
Published: (2019-12-01)

Management of the Elderly Patients with High-Grade Serous Ovarian Cancer in the REAL-WORLD Setting
by: Michalis Liontos, et al.
Published: (2021-03-01)

Nomograms to Predict the Density of Tumor-Infiltrating Lymphocytes in Patients With High-Grade Serous Ovarian Cancer
by: Danian Dai, et al.
Published: (2021-02-01)

Late recurrence of pStage 1 low-grade serous ovarian tumor presenting as a symptomatic bone metastasis: a case report
by: Chiaki Kubo, et al.
Published: (2018-06-01)

CYPA promotes the progression and metastasis of serous ovarian cancer (SOC) in vitro and in vivo
by: Zhi-Ying Qi, et al.
Published: (2019-11-01)

The Development and Validation of a CT-Based Radiomics Nomogram to Preoperatively Predict Lymph Node Metastasis in High-Grade Serous Ovarian Cancer
by: Hui-zhu Chen, et al.
Published: (2021-08-01)

Gastric metastasis of ovarian serous cystadenocarcinoma
by: Yang S
Published: (2018-09-01)

High-throughput approaches for precision medicine in high-grade serous ovarian cancer
by: Meinusha Govindarajan, et al.
Published: (2020-10-01)

Stromal infiltrating mast cells identify immunoevasive subtype high-grade serous ovarian cancer with poor prognosis and inferior immunotherapeutic response
by: Kankan Cao, et al.
Published: (2021-01-01)

Cathepsin L-induced galectin-1 may act as a proangiogenic factor in the metastasis of high-grade serous carcinoma
by: Md Zahidul I. Pranjol, et al.
Published: (2019-07-01)

EGFR and HER2 Expression in Primary Ovarian High-Grade Serous Carcinoma and Their Prognostic Value
by: Mayada S. Farrag, et al.
Published: (2021-06-01)

SNCG promotes the progression and metastasis of high-grade serous ovarian cancer via targeting the PI3K/AKT signaling pathway
by: Jing Zhang, et al.
Published: (2020-05-01)

Proteomic Discovery of Biomarkers to Predict Prognosis of High-Grade Serous Ovarian Carcinoma
by: Se Ik Kim, et al.
Published: (2020-03-01)

Mining TCGA database for gene expression in ovarian serous cystadenocarcinoma microenvironment
by: Youzheng Xu, et al.
Published: (2021-05-01)

Durable response to hormonal therapy in a patient with rapidly progressive low-grade serous ovarian cancer: A case report
by: Catherine H. Watson, et al.
Published: (2020-08-01)

Further Understanding of High-Grade Serous Ovarian Carcinogenesis: Potential Therapeutic Targets
by: Voutsadakis IA
Published: (2020-10-01)

Development of a Bioluminescent BRCA1-Deficient Xenograft Model of Disseminated, High-Grade Serous Ovarian Cancer
by: Yen Ting Shen, et al.
Published: (2019-05-01)

RNA Immune Signatures from Pan-Cancer Analysis Are Prognostic for High-Grade Serous Ovarian Cancer and Other Female Cancers
by: Wendell D. Jones, et al.
Published: (2020-03-01)

BRCA and early events in the development of high grade serous ovarian cancer
by: Sophia HL George, et al.
Published: (2014-01-01)

CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer—A Multicenter Analysis
by: Berchuck, A., et al.
Published: (2022)

Progression of choroidal metastasis of ovarian serous cystoadenocarcinoma after intravitreal bevacizumab treatment
by: Victor E. Reviglio, et al.
Published: (2013-02-01)

The prognostic value of ITGA and ITGB superfamily members in patients with high grade serous ovarian cancer
by: Tingting Zhu, et al.
Published: (2020-06-01)

Space-and Time-Resolved Metabolomics of a High-Grade Serous Ovarian Cancer Mouse Model
by: Botros, A., et al.
Published: (2022)

Identification of Novel Fusion Transcripts in High Grade Serous Ovarian Cancer
by: Andreea Newtson, et al.
Published: (2021-04-01)

Cytology positive pericardial effusion causing tamponade in patients with high grade serous carcinoma of the ovary
by: Joni Kooy, et al.
Published: (2020-08-01)

Progesterone Prevents High-Grade Serous Ovarian Cancer by Inducing Necroptosis of p53-Defective Fallopian Tube Epithelial Cells
by: Na-Yiyuan Wu, et al.
Published: (2017-03-01)

Distinct gene expression profiles associated with clinical outcomes in patients with ovarian clear cell carcinoma and high-grade serous ovarian carcinoma
by: Huimei Zhou, et al.
Published: (2020-04-01)

Importance of serous intraepithelial ovarian tubal carcinomas in the occurrence of "high-grade" serous carcinomas and / or peritoneal serous carcinomas of unknown primary origin.
by: I. S. Shponka, et al.
Published: (2020-04-01)

Integrated Proteomic and Glycoproteomic Characterization of Human High-Grade Serous Ovarian Carcinoma
by: Yingwei Hu, et al.
Published: (2020-10-01)

Pathogenic Heteroplasmic Somatic Mitochondrial DNA Mutation Confers Platinum-Resistance and Recurrence of High-Grade Serous Ovarian Cancer
by: Ni J, et al.
Published: (2020-11-01)

Therapeutic Approach to Low-Grade Serous Ovarian Carcinoma: State of Art and Perspectives of Clinical Research
by: Angiolo Gadducci, et al.
Published: (2020-05-01)

STING pathway expression in low‐grade serous carcinoma of the ovary: an unexpected therapeutic opportunity?
by: Jutta Huvila, et al.
Published: (2021-11-01)

Identification of Chemoresistance-Associated Key Genes and Pathways in High-Grade Serous Ovarian Cancer by Bioinformatics Analyses
by: Wu Y, et al.
Published: (2020-06-01)

Clinical Significance of Organic Anion Transporting Polypeptide Gene Expression in High-Grade Serous Ovarian Cancer
by: Martin Svoboda, et al.
Published: (2018-08-01)

A case of synchronous serous ovarian cancer and uterine serous endometrial intraepithelial carcinoma
by: Maho Shimizu, et al.
Published: (2021-06-01)

Cannot write session to /tmp/vufind_sessions/sess_47fi77d16r120lvnl6361uckdh